Hydrogen Peroxide → 4-[4-(quinolin-3-yl)-9H-carbazol-9-yl]-2-(4-hydroxy-3(R,S)-methylbutylamino)benzamide
Reaction equation
F[C:2]1[CH:9]=[C:8]([N:10]2[C:22]3[CH:21]=[CH:20][CH:19]=[C:18]([C:23]4[CH:24]=[N:25][C:26]5[C:31]([CH:32]=4)=[CH:30][CH:29]=[CH:28][CH:27]=5)[C:17]=3[C:16]3[C:11]2=[CH:12][CH:13]=[CH:14][CH:15]=3)[CH:7]=[CH:6][C:3]=1[C:4]#[N:5].C(=O)([O-])[O-:34].[K+].[K+].[NH2:39][CH2:40][CH2:41][CH:42]([CH3:45])[CH2:43][OH:44].[OH-].[Na+].OO>CS(C)=O.C(O)C>[N:25]1[C:26]2[C:31](=[CH:30][CH:29]=[CH:28][CH:27]=2)[CH:32]=[C:23]([C:18]2[C:17]3[C:16]4[C:11](=[CH:12][CH:13]=[CH:14][CH:15]=4)[N:10]([C:8]4[CH:7]=[CH:6][C:3]([C:4]([NH2:5])=[O:34])=[C:2]([NH:39][CH2:40][CH2:41][CH:42]([CH3:45])[CH2:43][OH:44])[CH:9]=4)[C:22]=3[CH:21]=[CH:20][CH:19]=2)[CH:24]=1Participants
Reactant 5
Product 1
Reagents, catalysts & solvents 2
Procedure
The process is carried out as in stage 2 of Example 3, but using 300 mg of 2-fluoro-4-[4-(quinolin-3-yl)-9H-carbazol-9-yl]benzonitrile, obtained according to stage 1 of Example 32, 301 mg of potassium carbonate and 1.50 g of 4-amino-2(R,S)-methylbutanol in 3 ml of dimethyl sulphoxide. 1.38 ml of a 1M aqueous solution of sodium hydroxide, 1.336 ml of a 30% aqueous solution of hydrogen peroxide and 7 ml of ethanol are then added to the reaction medium. After treatment as in stage 3 of Example 3, and then purification by flash chromatography on silica gel, elution being carried out with a mixture of dichloromethane and ethanol (95/5 by volume), followed by crystallization from 5 ml of ethyl acetate, 225 mg of 4-[4-(quinolin-3-yl)-9H-carbazol-9-yl]-2-(4-hydroxy-3(R,S)-methylbutylamino)benzamide are thus obtained in the form of a beige solid, the characteristics of which are the following:
Workup
- customobtained
- customAfter treatment as in stage 3 of Example 3, and then purification by flash chromatography
- washon silica gel, elution
- additionbeing carried out with a mixture of dichloromethane and ethanol (95/5 by volume)
- customfollowed by crystallization from 5 ml of ethyl acetate, 225 mg of 4-[4-(quinolin-3-yl)-9H-carbazol-9-yl]-2-(4-hydroxy-3(R,S)-methylbutylamino)benzamide
- customare thus obtained in the form of a beige solid
Sources & evidence
- ORD record
- ord-c314dac7f48e40bb8c1042d98f75736c
- Source dataset
- uspto-grants-2012_11
- Patent number
- US08309721B2
Reaction notes
Loading…